Etamine

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Etamine

Quick Facts

Property Description
Active Ingredient Ketamine hydrochloride
Form Solution, Nasal Spray, Oral Liquid
Pharmacological Class Dissociative Anesthetic
General Purpose Induces General Anesthesia and Sedation
Origin Synthetic Compound (Arylcyclohexylamine)

What Type of Medicine is Etamine?

Etamine is a prescription-only medicine whose active component is the powerful synthetic compound Ketamine. It belongs to a unique medical category known as the dissociative anesthetic class, which acts distinctly from traditional central nervous system depressants. This classification is clinically recognized because the drug creates a functional “disconnection” between the brain and the senses—the dissociative state—which is used for profound pain control and unresponsiveness during medical procedures.

Its core identity stems from the fact that its active ingredient, Ketamine hydrochloride, is chemically classified as an arylcyclohexylamine derivative. This ingredient has a long-standing role as a dissociative anesthetic utilized globally. This indicates that the drug is formally recognized for inducing a unique state of anesthesia.


Composition and Forms of Etamine

Etamine is generally prepared as a single-active ingredient product, formulated with only Ketamine hydrochloride suspended in an aqueous base. The drug is notable for its versatility, as it is manufactured in various forms, including a solution for intravenous and intramuscular injection or infusion, as well as specialized preparations like a nasal spray or oral liquid. This wide range of available forms is a distinguishing feature that allows for its use in diverse medical environments.

Chemically, Ketamine exists as a racemic mixture containing two mirror-image molecules. Its structural analogue, Esketamine, is the isolated S-enantiomer, representing a distinct form that is sometimes used in different therapeutic contexts.


What is the General Purpose of a Dissociative Anesthetic?

The general purpose of Etamine is to rapidly induce general anesthesia or deep procedural sedation when a patient needs to be completely comfortable and still for a medical intervention. The dissociative mechanism creates a strong, interruptive form of analgesia (pain relief) that is unlike the effect of standard opioid pain medications. Its use in typical scenarios, such as rapidly establishing procedural sedation for patients in an emergency setting, is a recognized application of its pharmacological profile. This profile makes it particularly useful for urgent procedures or when managing patients with unstable cardiovascular conditions.

Regulatory References

  1. NIH Drug Information Portal
  2. arylcyclohexylamine

What side effects are possible with Etamine?

Possible side effects and safety information

Official regulatory documents classify the safety profile of Etamine (Ketamine hydrochloride) based on effects across multiple physiological systems and frequency of occurrence. The profile is primarily characterized by two domains: transient psychological effects upon recovery and systemic cardiovascular changes.

Key Safety Classifications and Frequency

Adverse reactions involving psychological manifestations, known as Emergence Reactions (e.g., vivid imagery, hallucinations, confusion), are the most frequently classified effects, occurring in approximately 12% of patients according to FDA labeling. Elevation of blood pressure and pulse rate are also classified as frequently observed, typically maximizing shortly after administration.

System-Organ Class Officially Documented Effects
Psychiatric Disorders Emergence reactions, hallucinations, confusion, potential for dependence/tolerance.
Vascular/Cardiac Disorders Hypertension, tachycardia, hypotension, arrhythmia.
Respiratory Disorders Respiratory depression, apnea, laryngospasms.
Gastrointestinal Disorders Nausea, vomiting, anorexia.

Serious Adverse Reactions and Safety Constraints

Serious adverse reactions documented in regulatory sources include respiratory depression and apnea (especially with rapid administration), anaphylaxis, and cardiac decompensation. The drug is formally contraindicated in patients for whom a significant elevation in blood pressure would constitute a serious hazard (e.g., severe coronary disease or eclampsia).

Exposure-related organ toxicity is noted, with reports of renal and urinary disorders (such as cystitis and acute kidney injury) and hepatotoxicity associated specifically with extended or long-term use. Safety constraints advise caution for hazardous activities for 24 hours or more post-procedure due to potential residual effects.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Etamine is formally documented in regulatory sources and primarily affects the central nervous system, respiratory system, and cardiovascular system. Patients may experience signs of profound CNS depression, including marked sedation, stupor, and progression to coma. Life-threatening outcomes such as apnea (respiratory arrest) and cardiac arrest are officially stated risks, particularly when Etamine is used alongside other CNS depressants.

Regulators mandate that patients seek immediate medical attention or call emergency services immediately if an overdose is suspected or if symptoms such as profound sedation or difficulty breathing occur. Treatment consists entirely of supportive care and close monitoring, as no specific antidote is known for reversing Etamine's effects. Management procedures described in labeling include the use of mechanical support of respiration for respiratory depression and the administration of a short-acting barbiturate to manage severe emergence reactions. Monitoring of vital signs must be continuous.

Overdose Risk Area Documented Manifestations
CNS Marked sedation, stupor, coma, seizures
Cardiopulmonary Apnea, laryngospasm, arrhythmia, hypotension

Therapeutic Uses of Etamine

What Etamine Treats: Main Uses and Benefits

Etamine, whose active ingredient is Ketamine, is applied across therapeutic domains involving heightened responses to provide supportive relief during periods of heightened symptoms and acute distress. It is commonly used in contexts related to anesthesia, pain management, and specialized mood disorder management.


This medication is relevant in contexts involving heightened systemic burden, primarily to help establish a state of general anesthesia or deep procedural sedation in acute care scenarios. It is also used to help with groups of symptoms related to intense acute pain stemming from traumatic injuries and certain conditions characterized by periods of heightened symptoms like complex chronic pain syndromes, and to manage the distressing symptoms associated with treatment-resistant depression (TRD) and acute suicidal ideation.

This benefit contributes to improved day-to-day comfort during periods of heightened symptoms. It supports the patient during difficult episodes by easing distress and assists with maintaining a sense of stability when symptoms are more noticeable.


Quick Fact: Symptomatic Support

Symptom Domain General Benefit Provided Clinical Scenarios
Pain & Awareness Assists with managing discomfort and awareness Acute care scenarios, short-term procedures
Intense Pain Contributes to easing the overall symptom load Conditions with localized discomfort, recurrent pain patterns
Mood/Affective Distress May assist with maintaining functional stability Mood disorders involving heightened symptoms, acute episodes

Regulatory References

  1. NIH StatPearls overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Etamine?

The official regulatory profile for Etamine establishes population eligibility based on specific medical criteria, age, and physiological status.

Absolute Contraindications

Use is strictly prohibited for patients with a known hypersensitivity to Ketamine or any excipient. It is also contraindicated in individuals where a significant, transient elevation of blood pressure would constitute a serious hazard, such as those with severe heart disease, severe coronary/myocardial disease, or uncontrolled hypertension. Infants under three months of age are generally excluded from procedural sedation use.

Restrictions and Conditional Use

The medicine is generally not recommended for use in pregnant women because safe use has not been established in humans. Caution is advised for patients with elevated intracranial pressure, certain untreated thyroid disorders, or active psychiatric illness like psychosis.

While use is indicated in children, safety and effectiveness have not been formally established in all pediatric patients (e.g., those under 16 years in some labels), and prolonged use (over three hours) is discouraged in very young children (le 3 years). Older adults may require cautious, lower dosing due to potential changes in organ function. Long-term use is not indicated and is associated with risks of hepatotoxicity.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory documents for Etamine define interactions across pharmacodynamic, pharmacokinetic, and procedural domains.

Drug and Substance Restrictions

Co-administration is formally prohibited with Theophylline or Aminophylline due to the documented risk of lowering the seizure threshold. The injectable solution is also restricted from being mixed with Barbiturates or Diazepam in the same syringe or infusion fluid because of a confirmed chemical incompatibility and precipitate formation.

Pharmacodynamic and Metabolic Effects

The risk of profound sedation and respiratory depression is documented with the concomitant use of other CNS Depressants, including Opioid Analgesics, Benzodiazepines, and alcohol. Interactions with Sympathomimetics and Thyroid Hormones may lead to an additive increase in heart rate and blood pressure. Substances that affect metabolic enzymes, such as CYP Inducers (e.g., Rifampin) and CYP Inhibitors (e.g., Ticlopidine), are documented to alter systemic exposure (AUC and Cmax) of Etamine.

Special Administration Requirements

For the nasal spray formulation, a timing separation from consumption is required; specifically, food must be avoided for at least two hours and liquids for at least thirty minutes prior to administration. In patients with moderate hepatic impairment, longer monitoring may be required due to documented higher drug exposure.

Mechanism of Action

The core mechanism of Etamine involves the highly specific noncompetitive blockade of the N-methyl-D-aspartate ( NMDA) receptor, the primary channel for the excitatory neurotransmitter glutamate in the central nervous system. By physically lodging within this channel's pore, Etamine interrupts the flow of excitatory signals, particularly in the pathways responsible for processing sensory input and awareness.

This molecular action results in the functional disconnection of the thalamo-neocortical pathway, separating the brain's sensory relay center from the area of conscious thought, which is the neurophysiological basis for the characteristic dissociative state. The mechanism is multimodal, further involving the blockade of HCN1 ion channels and partial agonism at mu-opioid receptors, contributing to central interruption of nociception (pain transmission).

Additionally, the drug indirectly stimulates the central outflow of the sympathetic nervous system, leading to the release of endogenous catecholamines (adrenaline-like substances). This physiological response results in the maintenance or increase of cardiovascular tone (heart rate and blood pressure) during the drug's central effects.

Dosage and Administration Information

How Etamine is Used

Etamine (Ketamine hydrochloride) is administered exclusively within a clinical setting for the rapid establishment and maintenance of anesthesia. Its usage patterns are governed by established medical protocols focusing on precise administration methods and dose ranges.

Administration and Dosage Regimens

The medicine is administered via Intravenous (IV) injection, Intramuscular (IM) injection, or as a Continuous IV Infusion. It is supplied as a sterile solution in concentrations, including 10 mg/mL, 50 mg/mL, and 100 mg/mL.

Administration Route Standard Adult Dosing Administration Speed/Context
IV Induction Initial dose: 1.0 to 4.5 mg/kg (Avg. 2.0 mg/kg) Must be injected slowly over 60 seconds; high concentrations require dilution before use.
IM Induction Initial dose: 6.5 to 13 mg/kg Used when the intravenous route is impractical.
Maintenance Intermittent doses (half of induction dose) or Continuous IV Infusion (0.1 to 0.5 mg/minute) Used for short procedures; not intended for long-term use.

Key Procedural Instructions

Prior to induction, an antisialagogue (a drug to reduce salivation) is typically administered. The 100 mg/mL concentration must be diluted before IV administration, and the diluted solution must be used immediately after preparation. Etamine must not be mixed in the same syringe with barbiturates. Dosing in specific populations, such as in Obstetrics (IV doses less than or equal to 1.0 mg/kg) and in patients with hepatic impairment, may require special consideration or dose reduction.

Recent Clinical Evidence

Research evidence / Overview of Studies for Etamine


Evidence for Use in General Anesthesia and Procedural Sedation

Etamine was studied for its use in rapidly inducing a state of general anesthesia or deep procedural sedation, which are conditions associated with acute or disruptive episodes that typically require management of awareness and outcomes related to physical discomfort. The evidence base for this use includes decades of observational studies and clinical practice, systematic reviews, and earlier Randomized Controlled Trials (RCTs).

In these studies, researchers monitored patient outcomes related to physical discomfort and systemic or functional imbalance. Specifically, research examined the time it took for the dissociative state to begin, how long the effect lasted, and whether the patient was able to maintain their breathing and airway reflexes spontaneously. Studies also monitored physiological strain or stress by observing the status of cardiovascular parameters, such as heart rate and blood pressure, during the medical procedure.


Evidence for Use in Intense Acute Pain Management

Etamine was evaluated in trials exploring its role as an adjunct analgesic—meaning it was studied alongside other pain medications—in research exploring outcomes related to physical discomfort. This research primarily involved short-term Randomized Controlled Trials (RCTs) and systematic reviews.

Studies explored outcomes related to patient-reported discomfort, such as changes measured using standard pain scales. Research also monitored outcomes reflecting the patient's need for other pain medications, specifically quantifying how much opioid medication was used during the post-procedure observation period. Findings indicate patterns observed in the studies where Etamine, when used as an adjunct, studies examined the relationship between use and opioid consumption measurements. Research explored outcomes related to patient-reported pain intensity during the immediate acute phase of pain. However, results apply only to the populations studied, and findings were mixed depending on the specific type of injury or procedure.


Evidence for Use in Treatment-Resistant Depression Symptoms

Etamine has been studied for its use in conditions characterized by fluctuating or episodic manifestations, specifically in research contexts involving treatment-resistant depression (TRD) and acute suicidal ideation. This evidence is mostly derived from short-term RCTs and subsequent meta-analyses.

Research described changes measured in depression severity scores that occurred over short intervals in the observed populations. However, studies report how symptoms evolved in the observed populations, and the data show patterns where the observed changes were frequently noted to reverse within a few weeks. Long-term effects are not fully established for repeated administration protocols over periods of six months or more, and follow-up durations are limited.

Key Studies & References Ketamine: The Use of Ketamine in Anesthesia (StatPearls - NCBI Bookshelf)

Frequently Asked Questions (FAQ)

Common questions about Etamine (FAQ)

Q: Why do some people refer to Etamine as a 'new kind' of treatment?

Etamine’s active ingredient, Ketamine, has been used as an anesthetic for decades. However, a specific molecular form of the medicine, Esketamine, has recently received regulatory approval for new indications, such as treatment-resistant depression. This newer development, and the medicine’s unique method of action as a dissociative anesthetic, is likely why it is sometimes perceived as a novel or 'new kind' of treatment in certain contexts.

Q: What is the biggest difference between Etamine and older medications used for the same purpose?

Etamine is classified as a dissociative anesthetic, which is distinct from many traditional CNS depressants that cause sedation. The unique mechanism creates a 'functional disconnection' in the brain, providing pain control and unresponsiveness. Furthermore, official product information notes that it is noted for its ability to maintain or increase cardiovascular tone (heart rate and blood pressure) during the drug's central effects.

Q: Does Etamine cause weight gain or weight loss?

Official regulatory documents list gastrointestinal side effects such as nausea, vomiting, and anorexia (loss of appetite) as documented adverse reactions. While these effects are noted, weight gain or weight loss itself is not typically listed as a frequent or common side effect in the official safety profile.

Q: Is it common to feel tired when starting Etamine?

Though the term 'tiredness' or 'fatigue' is not explicitly listed as a primary side effect, the official label notes that the drug can cause sedation and confusion. Patient materials indicate that feeling sleepy is a known residual effect. Due to these potential effects, safety constraints indicate caution for hazardous activities for 24 hours or more post-procedure is advised.

Q: How long does it typically take to feel the effects of Etamine after I start taking it?

Etamine is classified as a rapid-acting medication. When administered intravenously (IV), the anesthetic effect generally begins very quickly, typically within one minute. The duration of the effect for short procedures is typically described as lasting 15 to 30 minutes, depending on the route and amount given.

Q: Is Etamine safe for people who have kidney issues?

Etamine is eliminated from the body primarily through the kidneys. While not an absolute prohibition for all patients with kidney issues, regulatory documents have noted reports of renal and urinary disorders (such as cystitis and acute kidney injury) associated with extended or high-dose use. Official guidance indicates that dose reduction or cautious use may be considered for patients with impaired kidney function.

Q: Why does the official leaflet mention a risk of 'Condition X'?

Official leaflets, mandated by regulatory bodies like the FDA, mention risks to ensure patients are fully informed. Warnings are included when serious risks, like respiratory depression, dissociation, sedation, or potential for abuse and misuse, are identified in clinical trials or through post-marketing data. These safety alerts are intended to call attention to important hazards.

Q: What is the risk of Etamine interacting with herbal supplements like St. John's Wort?

The official product information advises caution regarding substances that affect metabolic enzymes. Specifically, using Etamine with the herbal supplement St. John’s Wort may increase side effects such as dizziness, confusion, and excessive sedation. Official guidance indicates that patients should avoid or limit the use of this combination.

Q: Does research show Etamine is effective for treating all types of Condition Z?

Studies and regulatory reviews indicate that efficacy results typically apply only to the populations studied in the clinical trials. For example, in pain management research, findings were noted to be mixed depending on the specific type of injury or procedure. This indicates that results may vary depending on the specific type of condition.

Q: Does Etamine lose effectiveness over time (tolerance)?

Official product information lists the potential for tolerance as an adverse reaction. Tolerance can develop with repeated medical use, and this can lead to the need for larger amounts to achieve a similar effect in some individuals.

Q: What is the typical age range for people prescribed Etamine?

Etamine is regulated for use in both adults and children. Official guidelines note that use is generally prohibited for infants under three months of age. Additionally, the official guidance advises cautious, lower dosing for older adults.

Q: Can Etamine cause changes in mood or anxiety levels?

Yes, regulatory documents list a range of psychiatric disorders and emergence reactions. These can include hallucinations, confusion, and a temporary feeling of detachment from reality. For the nasal spray form, anxiety and suicidal thoughts and behaviors are also noted in the official boxed warning.

Q: Are there any dietary restrictions I need to be aware of while taking Etamine?

Dietary timing restrictions apply specifically to the nasal spray formulation. The label for the nasal spray formulation indicates that food should be avoided for at least two hours and liquids for at least 30 minutes prior to administration. This measure is intended to help reduce the potential for nausea and vomiting associated with the medicine.

Q: What is the likelihood of developing a serious side effect from Etamine?

The frequency varies greatly depending on the specific effect. The most common psychological effects (Emergence Reactions) occur in approximately 12% of patients. The risk of serious adverse effects, such as respiratory depression and apnea, is heavily influenced by the dose and the speed at which the medicine is administered.

Q: Is the onset of action for Etamine immediate or gradual?

The onset of action for Etamine is classified as rapid. Following intravenous administration, the anesthetic state is induced quickly, confirming that the effects are generally immediate rather than gradual.

Q: Why is regular monitoring often recommended when taking Etamine?

Monitoring is recommended due to the potential for significant, transient changes in vital signs, such as cardiovascular effects (increased blood pressure and heart rate). For the nasal spray form, patients are required to be monitored by a healthcare professional for at least two hours after each dose to manage potential sedation or dissociation.

Q: Does Etamine require a special prescription or monitoring program?

Yes, Etamine (Ketamine) is classified as a Schedule III controlled substance by the DEA, which mandates strict procedures for prescribing, dispensing, and storage. Additionally, the nasal spray form (Esketamine) is only available through a restricted distribution program called a Risk Evaluation and Mitigation Strategy (REMS), requiring continuous professional oversight.

Q: Can Etamine be taken on an empty stomach?

For the injectable solution, Official information states that Etamine is used in patients whose stomach is not empty during the procedure when the benefits outweigh the possible risks of aspiration. However, for the nasal spray form, a timing separation from food is necessary to reduce the risk of nausea and vomiting. The requirement may vary based on the specific form of the drug used.

Q: Will I have withdrawal symptoms if I stop using Etamine?

The drug label notes the potential for dependence and tolerance with use. In addition to this potential, medical case reports mention that some chronic high-dose users who discontinue the medicine have reported experiencing withdrawal symptoms, including anxiety, tremor, sweating, and palpitations.

Q: How is Etamine eliminated from the body?

Etamine is processed, or extensively metabolized, by enzymes in the liver. It is then eliminated from the body, primarily through the kidneys, with only a small portion of the drug excreted unchanged in the urine.

Q: What is the definition of the 'black box warning' mentioned for Etamine?

A Boxed Warning (commonly referred to as a 'black box warning') is the most serious type of safety alert required by the FDA on a drug’s label. It serves to draw attention to serious or potentially life-threatening risks. For the nasal spray, these risks include sedation, dissociation, respiratory depression, abuse potential, and suicidal thoughts or behaviors.

Q: What should I do if a side effect of Etamine seems concerning?

Official regulatory guidance directs users to seek immediate medical attention or call emergency services for severe symptoms like difficulty breathing, fainting, chest pain, or enhanced pressor responses. It is essential to contact the administering healthcare team quickly if a serious reaction is suspected.

Q: Is Etamine available as a generic medicine yet?

Yes, the FDA has approved generic versions of the Ketamine hydrochloride injectable solution. This generic availability means the medicine can be marketed by several different manufacturers.

Q: Can Etamine be crushed or split if the person has trouble swallowing pills?

Etamine is not typically formulated as a solid pill that would be crushed or split. It is manufactured in forms that do not require swallowing, such as a sterile solution for injection/infusion and a nasal spray. These alternatives address the need for administration when swallowing is difficult.

How should Etamine be stored and disposed of?

Storage and Disposal of Etamine

Official regulatory guidelines define specific storage and disposal requirements for Etamine (Ketamine/Esketamine).

Ketamine Hydrochloride Injection must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), and must be protected from light. The medication should not be frozen.

Stability and Handling

Once the injection solution is diluted, it must be used immediately. Any product must be discarded if discoloration or particulate matter is visible. The Esketamine nasal spray has a maximum 14-day limit for disposal if unused after receipt.

Child Safety and Disposal

All forms must be kept out of the sight and reach of children and stored in the original, tightly closed container.

Due to its classification as a Schedule III controlled substance, used devices and unused product must be disposed of as medical waste according to applicable federal, state, and local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Etamine found in:

A-Z Index: